Abstract
Objective: The aim of this study was to investigate the relationship between antioxidant markers (Superoxide Dismutase [SOD], Glutathione [GSH], Catalase, and Nitric Oxide [NO]) and the severity of ischemic stroke in affected individuals.
Methods: A randomized controlled, single-blind study was conducted from June 2022 to November 2024. The study included 364 patients aged 45-80 years diagnosed with ischemic stroke. Participants were randomly divided into two groups: Group A (n=193) received standard stroke rehabilitation therapy, while Group B (n=171) received additional antioxidant support. Serum levels of SOD, GSH, Catalase, and NO were measured. The severity of ischemic stroke was evaluated using the modified Rankin Scale (mRS) and NIH Stroke Scale (NIHSS), with follow-up evaluations conducted at 2-, 4-, and 6-months post-treatment.
Results: Among the 364 participants, 203 (55.7%) were male, and 161 (44.3%) were female, with a mean age of 67.3 ± 12.2 years. Serum SOD levels were higher in the experimental group (16.3 ± 3.7 U/mL) compared to the control group (12.5 ± 4.1 U/mL, p = 0.014). GSH levels were also significantly higher in the experimental group (178 ± 31 μmol/L) than in the control group (145 ± 26 μmol/L, p = 0.032). NO levels were higher in the experimental group (42.1 ± 8.6 μmol/L) than in the control group (35.4 ± 7.3 μmol/L, p = 0.021). Catalase levels were 52.3 ± 11.1 U/mL in the experimental group and 49.6 ± 10.2 U/mL in the control group, with no significant difference between the groups (p = 0.213). Significant inverse correlations were found between SOD, GSH, and NO levels and stroke severity (p < 0.05), but catalase showed no such correlation (p = 0.513).
Conclusion: This study identified a significant relationship between lower levels of SOD, GSH, and NO and more severe ischemic stroke outcomes. Higher levels of these antioxidants were associated with improved recovery. In contrast, catalase did not show a significant association with stroke severity or recovery, suggesting that SOD, GSH, and NO may play a more critical role in the pathophysiology of ischemic stroke.
Keywords
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.